Koneru Mythili 4
4 · Marker Therapeutics, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Koneru Mythili
Snr VP, Clinical Development
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-10+140,000→ 140,000 totalExercise: $3.29Exp: 2031-02-10→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.